Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JUNE ISSUE PUBLISHED
  • JUNE 2021 Issue has been successfully launched on 1 June 2021.

Abstract

MARFAN SYNDROME: AN OVERVIEW

Sereena Saju*, Maria K. Manu, Fedrin V. Varghese, Feba John, Bhavani Sekar, Dr. Samhitha Chetty, PharmD

ABSTRACT

Marfan syndrome (MFS) is a pleiotropic connective tissue disorder inherited as an autosomal dominant trait, due to mutations in the fibrillin-1 gene (FBN1). The understanding of the molecular functions of the fibrillin containing microfibrils is still obscure and correspondingly, no comprehensive pathogenetic theory of Marfan syndrome has emerged to date. The diagnosis remains clinical and is based on the revised Ghent nosology. Since, the cardiovascular complications remains the utmost risk factor for morbidity and mortality, the treatment includes prophylactic beta-blockers and angiotensin II-receptor blockers to slow down the dilation of the ascending aorta and prophylactic aortic surgery as a major contributing factor to MFS. However, due to advancement in medical and surgical therapy, life expectancy has improved dramatically. This review article aims to provide an overview of this rare hereditary disorder, by focusing on the epidemiology, etiology, clinical diagnosis based on revised Ghent criteria and recommendations for the management of affected individuals.

Keywords: Marfan syndrome, FBN1, TGF-?, revised Ghent nosology, aortic root dilatation (AoR), beta-blockers


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More